CAMP4 Therapeutics Corporation (CAMP) vs Lexeo Therapeutics, Inc. Common Stock (LXEO)
A side-by-side comparison of CAMP4 Therapeutics Corporation and Lexeo Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.84HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT
LXEO
Lexeo Therapeutics, Inc. Common Stock
$3.38HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
Total return — CAMP vs LXEO
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)LXEO -58.4% (-35.5%/yr)LXEO compounded faster over this window
CAMP LXEO
CAMP vs LXEO: by the numbers
- •LXEO is the larger company ($265M vs $241M market cap).
- •Both run net losses; LXEO's is the smaller (0.00% vs -2543.74% net margin).
Metrics side by side
Valuation
| Metric | CAMP | LXEO |
|---|---|---|
| P/S ratio | 57.18 | N/A |
| P/B ratio | N/A | 1.13 |
Profitability
| Metric | CAMP | LXEO |
|---|---|---|
| Gross margin | 53.14% | 0.00% |
| Operating margin | -1488.31% | 0.00% |
| Net margin | -2543.74% | 0.00% |
| ROE | N/A | -37.12% |
| ROIC | -69.76% | -39.76% |
Growth (annualized)
| Metric | CAMP | LXEO |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | N/A |
Go deeper
Dig into the metrics
CAMP4 Therapeutics ROELexeo Therapeutics, Inc. Common Stock ROECAMP4 Therapeutics operating marginLexeo Therapeutics, Inc. Common Stock operating marginCAMP4 Therapeutics revenue growthLexeo Therapeutics, Inc. Common Stock revenue growthCAMP4 Therapeutics free cash flowLexeo Therapeutics, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.